In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Neogen’s current price exceeds the $6.61 fair value estimate, signaling potential overvaluation with high confidence. Weak profitability and growth scores contrast liquidity and leverage strengths, increasing financial risk. Monte Carlo simulations show 100% downside risk below the current price, underscoring volatility and valuation uncertainty.